argenx SE - ADR

General ticker "ARGX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $37.0B

argenx SE - ADR follows the US Stock Market performance with the rate: 53.6%.

Estimated limits based on current volatility of 1.3%: low 622.69$, high 638.97$

Factors to consider:

  • Current price 20.6% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [241.98$, 522.18$]
  • 2024-12-30 to 2025-12-30 estimated range: [173.18$, 388.71$]

Financial Metrics affecting the ARGX estimates:

  • Negative: Non-GAAP EPS, $ of -6.30 <= 0.10
  • Negative: Operating profit margin, % of -25.74 <= 1.03
  • Negative: Operating cash flow per share per price, % of -1.65 <= 2.35
  • Negative: negative Net income

Similar symbols

Short-term ARGX quotes

Long-term ARGX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $497.28MM $410.75MM $1,226.32MM
Operating Expenses $846.02MM $1,130.41MM $1,651.37MM
Operating Income $-348.75MM $-719.66MM $-425.05MM
Non-Operating Income $-51.00MM $-9.65MM $120.55MM
Interest Expense $1.10MM $3.91MM $0.90MM
R&D Expense $580.52MM $663.37MM $755.11MM
Income(Loss) $-399.74MM $-729.31MM $-304.50MM
Taxes $8.52MM $-19.72MM $-9.44MM
Profit(Loss) $-408.26MM $-709.59MM $-295.05MM
Stockholders Equity $2,534.22MM $2,813.70MM $4,097.51MM
Inventory $109.08MM $228.35MM $310.55MM
Assets $2,850.27MM $3,134.26MM $4,542.46MM
Operating Cash Flow $-606.81MM $-862.81MM $-420.33MM
Capital expenditure $121.43MM $103.82MM $43.81MM
Investing Cash Flow $-347.07MM $-461.18MM $308.21MM
Financing Cash Flow $1,121.34MM $843.76MM $1,336.73MM
Earnings Per Share* $-7.99 $-13.05 $-5.16

* EPS are Split Adjusted, recent splits may be reflected with a delay.